Moleculin Biotech CS
(MBRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,112 | -14,076 | -6,436 | -21,763 | -19,464 |
| Depreciation Amortization | 81 | 59 | 31 | 126 | 95 |
| Other Working Capital | -1,324 | 371 | 706 | 231 | -815 |
| Other Operating Activity | 32,986 | 3,500 | 1,135 | -2,456 | 1,405 |
| Operating Cash Flow | $-17,369 | $-10,146 | $-4,564 | $-23,862 | $-18,779 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -13 | -13 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-13 | $-13 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,797 | 13,422 | 7,999 | 4,661 | 4,660 |
| Other Financing Activity | 0 | 0 | 0 | -26 | -26 |
| Financing Cash Flow | $19,797 | $13,422 | $7,999 | $4,635 | $4,634 |
| Exchange Rate Effect | -3 | 3 | 3 | -32 | 13 |
| Beginning Cash Position | 4,278 | 4,278 | 4,278 | 23,550 | 23,550 |
| End Cash Position | 6,703 | 7,557 | 7,716 | 4,278 | 9,405 |
| Net Cash Flow | $2,425 | $3,279 | $3,438 | $-19,272 | $-14,145 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,369 | -10,146 | -4,564 | -23,862 | -18,779 |
| Capital Expenditure | N/A | N/A | N/A | -13 | -13 |
| Free Cash Flow | -17,369 | -10,146 | -4,564 | -23,875 | -18,792 |